Pilot Observations From a Large Genetic Screening Study

Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3,167 Participants

Comprehensive understanding of a rare disorder requires the identification of a large number of patients. CENTOGENE has been running a pertinent screening study for Hereditary Transthyretin-Related Amyloidosis (hATTR) since 2018. An analysis of the first ~3,000 study participants revealed numerous novel insights into hATTR; it was published in Journal of Clinical Medicine.